HLA class I alleles, one known and one newly identified, are linked to allopurinol-induced severe cutaneous adverse reactions ...

Opus Genetics has completed a Type B Regenerative Medicine Advanced Therapy (RMAT) meeting with the US Food and Drug ...

Atara Biotherapeutics (ATRA) witnessed a jump in share price last session on above-average trading volume. The latest trend ...

Since 2023, the U.S. Food and Drug Administration (FDA) has not required animal testing, thanks in part to organoids, which ...

DNA isn't just a long string of genetic code, but an intricate 3D structure folded inside each cell. That means the tools ...

Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of a loss of $0.24 per share. This compares to earnings of $0.31 per share a ...

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -153.85% and +9.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in patients aged 6 years ...

Large-scale analyses connect genetic risk factors in lupus with ACR-82 clinical manifestations, suggesting genetic risk ...

Around 25 million Americans have a rare genetic disease, and many of them struggle with not only a lack of effective ...

Triple-negative breast cancer is one of the most aggressive and difficult cancers to treat. It can initially respond well to ...